General Information of the Compound
| Compound ID |
CP0448264
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-[3-[4-(2-Bromo-acetylamino)-phenyl]-2-(2-{2-[2-dibenzylamino-3-(4-hydroxy-phenyl)-propionylamino]-acetylamino}-acetylamino)-propionylamino]-4-methyl-pentanoic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C44H51BrN6O8
|
||||||||||||||||||
| Molecular Weight |
871.83
|
||||||||||||||||||
| Canonical SMILES |
CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(NC(=O)CBr)cc1)NC(=O)CNC(=O)CNC(=O)C(Cc1ccc(O)cc1)N(Cc1ccccc1)Cc1ccccc1)C(O)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C44H51BrN6O8/c1-29(2)21-37(44(58)59)50-42(56)36(22-30-13-17-34(18-14-30)48-39(53)24-45)49-41(55)26-46-40(54)25-47-43(57)38(23-31-15-19-35(52)20-16-31)51(27-32-9-5-3-6-10-32)28-33-11-7-4-8-12-33/h3-20,29,36-38,52H,21-28H2,1-2H3,(H,46,54)(H,47,57)(H,48,53)(H,49,55)(H,50,56)(H,58,59)/t36-,37-,38?/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
KPPZFLDCDSRLHB-CYQHNISFSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01791, Delta-type opioid receptor
Protein ID: PT01526, Delta-type opioid receptor